Showing 1 - 20 results of 38 for search 'Johannes M. F. G. Aerts', query time: 0.06s
Refine Results
-
1
Plant Glycosides and Glycosidases: A Treasure-Trove for Therapeutics by Kassiani Kytidou, Marta Artola, Marta Artola, Herman S. Overkleeft, Johannes M. F. G. Aerts
Published 2020-04-01
Article -
2
-
3
Glycosphingolipids and Infection. Potential New Therapeutic Avenues by Johannes M. F. G. Aerts, M. Artola, M. van Eijk, M. J. Ferraz, R. G. Boot
Published 2019-12-01
Article -
4
-
5
-
6
a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy by Marina Moraitou, Georgios Sotiroudis, Nikolaos Papagiannakis, Maria M. J. Ferraz, Aristotelis Xenakis, Johannes M. F. G. Aerts, Leonidas Stefanis, Helen Michelakakis
Published 2023-01-01
Article -
7
a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy. by Marina Moraitou, Georgios Sotiroudis, Nikolaos Papagiannakis, Maria M J Ferraz, Aristotelis Xenakis, Johannes M F G Aerts, Leonidas Stefanis, Helen Michelakakis
Published 2023-01-01
Article -
8
-
9
Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial by Maaike de Fost, Johannes M.F.G. Aerts, Johanna E.M. Groener, Mario Maas, Erik M. Akkerman, Maaike G. Wiersma, Carla E.M. Hollak
Published 2007-02-01
Article -
10
Label-free LC-MSe in tissue and serum reveals protein networks underlying differences between benign and malignant serous ovarian tumors. by Wouter Wegdam, Carmen A Argmann, Gertjan Kramer, Johannes P Vissers, Marrije R Buist, Gemma G Kenter, Johannes M F G Aerts, Danielle Meijer, Perry D Moerland
Published 2014-01-01
Article -
11
Therapeutic challenges in two adolescent male patients with Fabry disease and high antibody titres by Aizeddin A. Mhanni, Christiane Auray-Blais, Michel Boutin, Alie Johnston, Kaye LeMoine, Jill Patterson, Johannes M.F.G. Aerts, Michael L. West, Cheryl Rockman-Greenberg
Published 2020-09-01
Article -
12
Skin barrier lipid enzyme activity in Netherton patients is associated with protease activity and ceramide abnormalities[S] by Jeroen van Smeden, Hanin Al-Khakany, Yichen Wang, Dani Visscher, Nicole Stephens, Samira Absalah, Herman S. Overkleeft, Johannes M.F.G. Aerts, Alain Hovnanian, Joke A. Bouwstra
Published 2020-06-01
Article -
13
Renal involvement in a patient with the chronic visceral subtype of acid sphingomyelinase deficiency resembles Fabry disease by Eline C. B. Eskes, Martijn J. C. van derLienden, Joris J. T. H. Roelofs, Liffert Vogt, Johannes M. F. G. Aerts, Jan Aten, Carla E. M. Hollak
Published 2021-11-01
Article -
14
Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C disease by Simon Wheeler, Per Haberkant, Meenakshi Bhardwaj, Paige Tongue, Maria J. Ferraz, David Halter, Hein Sprong, Ralf Schmid, Johannes M.F.G. Aerts, Nikol Sullo, Dan J. Sillence
Published 2019-07-01
Article -
15
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg. by Anouk C Vedder, Gabor E Linthorst, Gunnar Houge, Johannna E M Groener, Els E Ormel, Berto J Bouma, Johannes M F G Aerts, Asle Hirth, Carla E M Hollak
Published 2007-07-01
Article -
16
Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards. by Gertjan Kramer, Yvonne Woolerton, Jan P van Straalen, Johannes P C Vissers, Nick Dekker, James I Langridge, Robert J Beynon, Dave Speijer, Auguste Sturk, Johannes M F G Aerts
Published 2015-01-01
Article -
17
-
18
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector by Maria Dahl, Emma M.K. Smith, Sarah Warsi, Michael Rothe, Maria J. Ferraz, Johannes M.F.G. Aerts, Azadeh Golipour, Claudia Harper, Richard Pfeifer, Daniella Pizzurro, Axel Schambach, Chris Mason, Stefan Karlsson
Published 2021-03-01
Article -
19
Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes. by Wouter W Kallemeijn, Saskia Scheij, Sascha Hoogendoorn, Martin D Witte, Daniela Herrera Moro Chao, Cindy P A A van Roomen, Roelof Ottenhoff, Herman S Overkleeft, Rolf G Boot, Johannes M F G Aerts
Published 2017-01-01
Article -
20
Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes by Laura van Dussen, Timothy M. Cox, Erik J. Hendriks, Elizabeth Morris, Erik M. Akkerman, Mario Maas, Johanna E. M. Groener, Johannes M.F.G. Aerts, Patrick B. Deegan, Carla E. M. Hollak
Published 2012-12-01
Article